Sale!

DYNC1H1 Gene Mental Retardation Autosomal Dominant Type 13 Genetic Test

4,400 د.إ

-21%

The DYNC1H1 gene plays a crucial role in the development and function of the nervous system. Mutations in this gene are associated with Mental Retardation Autosomal Dominant Type 13 (MRD13), a condition characterized by intellectual disabilities and, in some cases, neurological and muscular impairments. The genetic test for MRD13 focuses on identifying mutations in the DYNC1H1 gene to confirm a diagnosis, guide treatment options, and offer genetic counseling.

At DNA Labs UAE, individuals can undergo the DYNC1H1 Gene Mental Retardation Autosomal Dominant Type 13 Genetic Test. This test is meticulously designed to detect the specific genetic alterations within the DYNC1H1 gene that are linked to the condition. With a cost of 4400 AED, the test provides a valuable resource for families seeking answers about MRD13, enabling them to make informed decisions about their health and care. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the lab for the presence of mutations in the DYNC1H1 gene. Results from this test can offer crucial insights into the condition, facilitating personalized treatment plans and supporting early intervention strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DYNC1H1 Gene Mental Retardation Autosomal Dominant Type 13 Genetic Test

Test Name: DYNC1H1 Gene Mental retardation autosomal dominant type 13 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for DYNC1H1 Gene Mental retardation, autosomal dominant type 13 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DYNC1H1 Gene Mental retardation, autosomal dominant type 13.

Test Details

The DYNC1H1 gene is associated with a condition called mental retardation, autosomal dominant type 13. This genetic test uses next-generation sequencing (NGS) technology to analyze the DYNC1H1 gene and identify any genetic variations or mutations that may be causing the condition. NGS is a high-throughput sequencing method that allows for the analysis of multiple genes simultaneously, providing a comprehensive view of the genetic variations within the DYNC1H1 gene.

This test can help in the diagnosis of mental retardation, autosomal dominant type 13 and provide valuable information for genetic counseling and management of the condition. It is important to note that a positive test result does not necessarily mean that an individual will develop the condition, as the presence of a genetic variation does not always result in the manifestation of symptoms. Additionally, a negative test result does not completely rule out the possibility of having the condition, as there may be other genetic or environmental factors involved.

It is recommended to consult with a healthcare professional or genetic counselor for a thorough evaluation of the test results and to discuss any potential implications or further testing options.

Test Name DYNC1H1 Gene Mental retardation autosomal dominant type 13 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for DYNC1H1 Gene Mental retardation, autosomal dominant type 13 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with DYNC1H1 Gene Mental retardation, autosomal dominant type 13
Test Details

The DYNC1H1 gene is associated with a condition called mental retardation, autosomal dominant type 13. This genetic test uses next-generation sequencing (NGS) technology to analyze the DYNC1H1 gene and identify any genetic variations or mutations that may be causing the condition.

NGS is a high-throughput sequencing method that allows for the analysis of multiple genes simultaneously, providing a comprehensive view of the genetic variations within the DYNC1H1 gene. This test can help in the diagnosis of mental retardation, autosomal dominant type 13 and provide valuable information for genetic counseling and management of the condition.

It is important to note that a positive test result does not necessarily mean that an individual will develop the condition, as the presence of a genetic variation does not always result in the manifestation of symptoms. Additionally, a negative test result does not completely rule out the possibility of having the condition, as there may be other genetic or environmental factors involved.

It is recommended to consult with a healthcare professional or genetic counselor for a thorough evaluation of the test results and to discuss any potential implications or further testing options.